Chenicheri Hariharan Nair
Keine laufenden Positionen mehr
Karriereverlauf von Chenicheri Hariharan Nair
Ehemalige bekannte Positionen von Chenicheri Hariharan Nair
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MEMPHASYS | Direktor/Vorstandsmitglied | 22.06.2011 | 29.11.2013 |
| Präsident | 16.10.2009 | 01.12.2012 | |
Arturus Capital Ltd.
 Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Direktor/Vorstandsmitglied | 01.01.2004 | 22.12.2007 |
PrIME Biologics Pte Ltd.
 PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Vorsitzender | - | - |
Ausbildung von Chenicheri Hariharan Nair
| Australian National University | Doctorate Degree |
Statistik
International
| Australien | 4 |
| Singapur | 2 |
Operativ
| Director/Board Member | 2 |
| President | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEMPHASYS | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Arturus Capital Ltd.
Arturus Capital Ltd. Financial ConglomeratesFinance Arturus Capital Ltd. is an investment company that holds interests in mining and gas projects. The company was founded on May 31, 1972 and is headquartered in North Perth, Australia. | Finance |
PrIME Biologics Pte Ltd.
PrIME Biologics Pte Ltd. BiotechnologyHealth Technology PrIME Biologics Pte Ltd. develops disposable therapeutic plasma manufacturing process. Its process doubles product yields while increasing product safety and removing viruses, bacteria, endotoxins, and prions. The firm’s process reduces the time it takes to produce multiple plasma products from days to hours. The company is headquartered in Singapore. | Health Technology |
